Download Citation
Article Source:
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers
Malvy D,
Taburet AM,
de Lamballerie X,
Mentre F,
Extramiana F
(2020)
The safety profile of favipiravir should not be the first argument to suspend its evaluation in viral hemorrhagic fevers.
PLOS Neglected Tropical Diseases 14(6): e0008259.
https://doi.org/10.1371/journal.pntd.0008259